Newborn Persistent Hypoglycemia Clinical Pathway — N/IICU
Newborn Persistent Hypoglycemia Clinical Pathway — N/IICU
Interpretation of Critical Fasting Labs
Acidemia
Non-Acidemia
Elevated Lactate
Elevated
β-hydroxybutyrate
β-hydroxybutyrate
Free Fatty Acid High,
β-hydroxybutyrate Low
β-hydroxybutyrate Low
Free Fatty Acid Low,
β-hydroxybutyrate Low
β-hydroxybutyrate Low
- Possible Diagnoses:
- GSD 1
- Fructose 1, 6
- Bisphosphatase deficiency
- PC deficiency
- Hereditary fructose intolerance
- Possible Diagnoses:
- Growth hormone deficiency
- Cortisol deficiency
- Glycogen storage diseases
- 0,3,6,9
- Ketotic hypoglycemia
Possible Diagnoses:
FAO defects
FAO defects
- Possible Diagnoses:
- Hyperinsulinism
- Consider hypopituitarism in neonates
- In the normal fasting state:
- Beta-hydroxybutyrate and FFA from fat breakdown are present with prolonged fasting and expect to be > 2.5 mmol/L
- Insulin and C-peptide should be undetectable
- IGFBP-1 is regulated by insulin and should be high when insulin is suppressed during hypoglycemia
- Low cortisol and growth hormone are not diagnostic of hormone deficiencies. Hormone replacement should not be initiated without confirmation of these diagnoses through stimulation testing